Skip to main content

Table 6 Statistical comparison between the results obtained by the proposed and reference methods

From: Green synchronous spectrofluorimetric analysis of remdesivir, the first approved antiviral, with levodropropizine as add-on therapy for covid-19: application in their pharmaceutical dosage form, and spiked human plasma

Parameters

Remdesivir

Levodropropizine

Proposed method

Reference method [19]

Proposed method

Reference method [39]

Number of measurements

5

5

5

5

Mean Recovery %

100.40

98.93

99.45

101.14

RSD %

1.331

0.740

1.447

0.930

Variance

1.785

0.535

2.070

0.885

Student’s t-testa (2.306)

2.158

——

2.201

——

F-valuea (6.388)

3.334

——

2.339

——

  1. a The values in parenthesis are tabulated values of “t ” and “F ” at (P = 0.05)